Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Fractyl Health, Inc. before investing.

In this article, we go over a few key elements for understanding Fractyl Health, Inc.’s stock price such as:

• Fractyl Health, Inc.’s current stock price and volume
• Why Fractyl Health, Inc.’s stock price changed recently
• Upgrades and downgrades for GUTS from analysts
• GUTS’s stock price momentum as measured by its relative strength

About Fractyl Health, Inc. (GUTS)

Before we jump into Fractyl Health, Inc.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Want to learn more about Fractyl Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Fractyl Health, Inc..

Fractyl Health, Inc.’s Stock Price as of Market Close

As of December 02, 2025, 4:00 PM, CST, Fractyl Health, Inc.’s stock price was $1.840.

Fractyl Health, Inc. is 0% from its previous closing price of $1.840.

During the last market session, Fractyl Health, Inc.’s stock traded between $1.420 and $1.850. Currently, there are approximately 64.65 million shares outstanding for Fractyl Health, Inc..

Fractyl Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Fractyl Health, Inc. Stock Price History

Fractyl Health, Inc.’s (GUTS) price is currently up 17.2% so far this month.

During the month of December, Fractyl Health, Inc.’s stock price has reached a high of $1.850 and a low of $1.420.

Over the last year, Fractyl Health, Inc. has hit prices as high as $3.030 and as low as $0.825. Year to date, Fractyl Health, Inc.’s stock is down 10.68%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Fractyl Health, Inc. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 02, 2025, there were 0 analysts who downgraded Fractyl Health, Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Fractyl Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Fractyl Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Fractyl Health, Inc. (GUTS) by visiting AAII Stock Evaluator.

Relative Price Strength of Fractyl Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 02, 2025, Fractyl Health, Inc. has a weighted four-quarter relative price strength of 10.65%, which translates to a Momentum Score of 84 and is considered to be Very Strong.

Want to learn more about how Fractyl Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Fractyl Health, Inc. Stock Price: Bottom Line

As of December 2, 2025, Fractyl Health, Inc.’s stock price is $1.840, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Fractyl Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.